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suggests a diagnostic value of the observed effect. How-
ever, the possible application of the method in forensic dif-
ferentiation diagnostics between suicidal and non-suicidal 
death needs further research.
Keywords Post-mortem · Suicide · Dorsal raphe 
nucleus · AgNOR staining
Introduction
Disturbances of the central serotonergic system are impli-
cated in a multifaceted way in suicidal behaviour (for 
reviews see: [1, 2]), which has been proposed to be an inde-
pendent mental disorder in the fifth edition of the Diagnos-
tic and Statistical Manual of Mental Disorders—DSM V 
[3] in accordance with numerous neurobiological research 
data (for reviews see: [1, 2]).
As revealed by neuropathological research on suicide, 
abnormalities in the serotonergic system may be structur-
ally restricted to a specific brain region, the dorsal raphe 
nucleus (DRN), which affects brain circuits (for a review 
see: [4]). DRN neurons provide the major serotonergic 
innervation to the prefrontal cortex (PFC) [5–7], which 
plays a pivotal role in behavioural regulation. Limbic 
regions of the PFC (i.e. the anterior cingulate cortex and 
the orbitofrontal cortex) in turn may reciprocally regulate 
DRN function through direct pyramidal input [8, 9] modu-
lated by serotonergic receptors in the PFC (for reviews see: 
[10–13]).
A number of post-mortem studies revealed changes in 
the DRN of suicide victims [14–28]. However, discrep-
ancies resulting from various factors exist in the studies. 
Inconsistencies regarding psychiatric diagnosis, treat-
ment, cause of death, the delineation of investigated areas, 
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methodical issues and small sample sizes seem to be the 
most significant [29].
Nucleolar organising regions (NORs) are genetic loci 
on chromosomes that are composed of ribosomal DNA 
(rDNA) and proteins, some of which are argyrophilic. In 
human interphase cells, silver-stained NORs (AgNORs) 
clustered together in the nucleolus represent the site of 
transcriptionally active NORs and ribosomal RNA syn-
thesis, which constitutes approximately one half of entire 
transcriptional activity in the cell. In the AgNOR staining 
evaluated by light microscopy, AgNORs are indistinguish-
able from each other and form the AgNOR area. They are 
located in the nucleolar area, but smaller than this area 
(compared, for instance, with haematoxylin–eosin and 
Nissl staining [30]). As a surrogate marker of protein bio-
synthesis and an important sensor of cellular stress of dif-
ferent nature, the transcriptional activity of rDNA can be 
assessed by measuring AgNOR parameters. These are: 
AgNOR area (representing the nucleolus), AgNOR number 
(i.e. the number of AgNOR areas within one nucleus) and 
AgNOR ratio defined as the quotient of total AgNOR area 
in the nucleus and nuclear area [18, 24, 31–42] (for reviews 
see: [43, 44]).
A key role of rDNA transcriptional activity in neu-
ronal plasticity has been proven in neuronal culture [45], 
and molecular studies have revealed that this activity is 
decreased in the suicidal hippocampus [46]. Our previ-
ous AgNOR studies of the DRN [24, 47] and other brain 
structures [33–37] in depression have suggested disturbed 
(predominantly decreased) rDNA transcription in neurons, 
specifically in suicidal patients, which is consistent with 
molecular results [46].
In the present study, we hypothesised a decreased rDNA 
transcriptional activity in DRN neurons in suicide com-
pleters regardless of their underlying psychiatric diagnosis 
(i.e. independent on psychiatric comorbidity) and tested 
this hypothesis by the application of the AgNOR staining 
method in our forensic post-mortem material. We aimed at 
both basic research on the neurobiology of suicide and the 
evaluation of possible diagnostic usefulness of the method 




Brainstems of suicide victims with unknown psychiatric 
comorbidity (typical for most of the suicide cases autopsied 
in our Department of Forensic Medicine) and sudden death 
controls were obtained during routine forensic autopsies in 
accordance with existing EU law regulations. The study has 
been approved by the local ethics committee of the Medical 
University of Gdan´sk and performed in accordance with the 
ethical standards laid down in the Declaration of Helsinki 
of 1989.
Detailed diagnostic, demographic and toxicological data 
together with raw data of AgNOR measurements are pre-
sented in Supplementary Table. Violent suicide methods 
prevailed in the suicide cohort (23 out of 27), which are 
representative for our autopsy material. All brains were free 
of gross neuropathology suggestive of vascular, traumatic, 
inflammatory, neoplastic and neurodegenerative processes. 
A toxicology screening on blood and urine for ethanol 
was performed at each autopsy. The majority of investi-
gated cases (17 suicide victims and 28 controls, see Sup-
plementary Table) revealed the blood alcohol concentration 
(BAC) below the limit of quantification (LOQ), i.e. <0.2 g/l 
according to internationally accepted analytical guidelines. 
Other substances of abuse, antidepressant and antipsychotic 
drugs, as well as their metabolites were investigated when 
an intoxication was suggested by the scene inspection and/
or other available information sources prior to the autopsy, 
i.e. in three cases. These cases together with a helium inha-
lation victim constituted the non-violent suicide subgroup 
(see Supplementary Table).
Brainstems were isolated from the brains and fixed in 
toto in 10 % phosphate-buffered formaldehyde for 1 week. 
After being fixated, tissue blocks containing the entire 
DRN were isolated from the brainstems and embedded in 
paraffin. Subsequently, serial 5-µm-thick transverse sec-
tions were cut along the entire rostrocaudal axis of the 
DRN. Every 200th section was mounted and stained for 
AgNOR.
AgNOR staining
Silver staining was carried out as previously described 
[24]. Briefly, 5-µm paraffin sections were dewaxed and 
rehydrated through graded alcohols. The silver staining 
was freshly prepared by dissolving 2 g/dl gelatin in 1 ml/
dl aqueous silver nitrate solution at a 1:2 ratio. The sections 
were incubated with this solution in a dark moist chamber 
at room temperature for 45 min and subsequently washed 
with deionised water. Following this protocol, the AgNOR 
area—containing AgNORs (that are clustered, undistin-
guishable from each other) and representing the nucleo-
lus—appears as an intranuclear, clearly delineated black 
or dark brown small spot, and the nuclear border is clearly 
visible in the majority of large DRN neurons (Fig. 1), 
which are most probably serotonergic output neurons [48]. 
Glia cells were distinguished from neurons according to the 
established cytomorphological criteria [49].
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Quantification
In each of the DRN subnuclei (ventral, ventrolateral, dor-
sal, interfascicular and caudal [48]), AgNOR parameters 
were determined in 40 neurons with clearly visible bor-
ders of the nucleus and AgNOR areas (Fig. 1), which were 
selected throughout the available AgNOR-stained sec-
tions, i.e. in seven sections for a case, on average. Thus, 
the AgNOR parameters of 200 DRN neurons were investi-
gated in each case. The number of investigated neurons was 
established arbitrarily in accordance with the guidelines on 
quantitative evaluation and diagnostic and research stud-
ies employing the AgNOR method. This method does not 
require an estimation of the number of cells and/or nuclei 
[24]. The neurons were sampled using a 400× magnifica-
tion. The AgNOR areas (composed of clustered AgNORs 
and representing the nucleoli), their number and the nuclear 
area within a single-sampled neuron were determined using 
a light microscope attached to a computer image analysis 
system (cellSens®, Olympus, Japan). In this system, each 
of the neurons sampled by 400× magnification was visu-
alised digitally and focused, and the sharpest and longest 
profiles of the nucleus and AgNOR areas were traced by 
the mouse cursor on the screen. As a result, the numerical 
values of AgNOR and the nuclear areas and the numbers of 
AgNOR areas were calculated automatically. Subsequently, 
the AgNOR ratio (relative AgNOR area) was derived by 
dividing the total AgNOR area by the nuclear area, tak-
ing into account all the AgNOR areas present per neuronal 
nucleus. This procedure was performed separately for each 
of the sampled neurons. The sampled measures were aver-
aged to derive a single set of values for each DRN subnu-
cleus, for the rostral and caudal subdivisions of the DRN 
and for the entire DRN as a single anatomical structure in 
each of the investigated cases.
Data analysis
Statistical analyses were performed with the data analysis 
software system STATISTICA version 10 (StatSoft®, Inc. 
2011, www.statsoft.com). As normal distribution was not 
given for all analysed AgNOR parameters, nonparametric 
statistical procedures were used. Unadjusted two-way com-
parisons with the Mann–Whitney U test were carried out to 
detect between-group differences.
The χ2 test and the U test were used to detect the pos-
sible differences between the study groups with respect to 
sex, age, season of the year (month of death in spring/sum-
mer vs. autumn/winter), brain weight, post-mortem delay 
and BAC (whose values below LOQ were accounted null 
values in statistical analysis). All statistical tests were two 
tailed.
Spearman correlation coefficients were calculated to 
determine the impact of numerical variables which might 
confound the dependent variables.
Generally, P values of <0.05 were accepted as statisti-
cally significant.
STATISTICA Automated Neuronal Networks (SANN) 
module containing receiver operating characteristic (ROC) 
procedure was applied for the evaluation of potential diag-
nostic value of the method, i.e. its accuracy (represented by 
the area under ROC curve), sensitivity and specificity.
Results
Qualitative analysis of the AgNOR staining
After AgNOR staining of the DRN neurons, borders of 
the AgNOR area (containing AgNORs that were clus-
tered together and indistinguishable from each other) were 
clearly visible (Fig. 1) in line with the staining patterns in 
DRN neurons presented previously [24]. Most of the neu-
rons contained one AgNOR area (representing the nucleo-
lus in this staining method). Two or more AgNOR areas 
were observed very rarely, which explains why the AgNOR 
number was near 1.
Fig. 1  After AgNOR staining, the borders of AgNOR areas (rep-
resenting nucleoli) (n) are clearly visible within nuclei (N) of DRN 
neurons (control case, interfascicular subnucleus, scale bar 20 µm). 
The differences in AgNOR parameters were beyond qualitative evalu-
ation, and they could only be captured by means of quantitative meas-
urements
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Quantitative analysis of the AgNOR staining
The differences in AgNOR parameters were beyond quali-
tative evaluation, and they could only be captured by means 
of quantitative measurements.
The statistical analysis revealed highly significant differ-
ences by means of the cumulative analysis of all DRN sub-
nuclei. Both the AgNOR area and the relative AgNOR area 
were decreased in suicide victims compared to controls 
(Table 1). No significant differences existed in any of the 
AgNOR parameters between violent (n = 23) and non-vio-
lent (n = 4) suicide victims. As revealed by the ROC curve 
for the AgNOR area, the method accuracy (represented 
by the area under ROC curve, AUC) is 83 %; its sensitiv-
ity according to the suicide diagnosis is 67 %, whereas the 
specificity of suicide exclusion (i.e. the diagnosis of non-
suicidal case) is 90 %. The respective values for the relative 
AgNOR area are: 85 % (AUC), 78 % (sensitivity) and 90 % 
(specificity), and for both parameters when tested simulta-
neously they are: 89 % (AUC), 85 % (sensitivity) and 87 % 
(specificity).
Confounders
Variables which could influence the AgNOR parameters 
in the DRN neurons, such as post-mortem interval (PMI), 
sex, age at death, season of the year (month of death in 
spring/summer vs. autumn/winter) and brain weight were 
not associated with the values of the AgNOR parameters 
in the compared groups. No significant differences in these 
variables between suicides and controls were revealed. 
As the PMI is a very important confounder in post-mor-
tem research, the hypothetical influence of this factor was 
excluded by an additional analysis of data. The cases with 
longest PMI (i.e. ≥70 h, 6 cases in suicidal and 3 in con-
trol group, see Supplementary Table) were separated, and 
AgNOR parameters were compared between them and 
remaining cases in respective groups, which revealed non-
significant U test P values. Moreover, intergroup compari-
sons were performed after exclusion of these cases, which 
supported the highly significant differences between sui-
cidal and control groups in both the AgNOR area (U test 
P value 0.000046) and the relative AgNOR area (U test P 
value 0.000007; for a comparison see Table 2).
Although males unequivocally prevailed in suicidal 
versus control group (χ2 test P value 0.0002, Table 2), no 
intragroup differences related to sex were found in any of 
AgNOR parameters, among them the AgNOR area and the 
relative AgNOR area (non-significant U test P values).
Discussion
Our study revealed a significantly decreased AgNOR area 
in DRN neurons suggestive of their decreased rDNA tran-
scriptional activity in suicide victims versus controls. The 
observed effect was not confounded by other variables, 
among them post-mortem interval. The significance was 
shown in the cumulative analysis of all DRN subnuclei. 
This phenomenon could be related to the characteristic of 
DRN connections with target structures which overlap [5–
7] in spite of the accentuated distinctiveness [50, 51].
The results are in line with our previously published 
findings, which suggested a decreased rDNA transcription 
in DRN neurons specific to depressed suicide completers 
(from both major depressive disorder and bipolar disorder 
diagnostic groups of affective disorders) compared to non-
suicidal depressed patients from these diagnostic groups 
[24]. Our recent findings in schizophrenia suggest a simi-
lar effect in suicidal compared to non-suicidal patients 
[52]. Therefore, our both previous and present results may 
suggest that the decreased rDNA transcription in DRN 
neurons is accentuated in suicide regardless of psychiat-
ric comorbidity. In this way, they correspond also with the 
well-established view on serotonergic hypofunction as a 
diagnose-overreaching neurobiological phenomenon symp-
tomatic of suicidal behaviour [1, 2, 4].
Regardless of the high statistical significance of our 
results (U test P < 0.00001), both the AgNOR area and the 
AgNOR ratio values overlapped between the suicide and 
Table 1  Presentation of significant diagnostic group differences 
regarding the evaluation of rDNA transcriptional activity in dorsal 
raphe nucleus neurons by the AgNOR staining (for the detailed val-
ues of parameters see Supplementary Table 1)
S suicide victims, C controls, q1 and q3 quartile 1 and 3, n number of 
cases, U test P U test P values, ns non-significant
Parameter and group Parameter values U test P
Median (q1, q3, n) S/C
Nuclear area in µm2 ns
 S 117.425 (105.715, 127.415, 
27)
 C 113.619 (101.426, 127.506, 
30)
AgNOR area in µm2 per 
nucleus
0.000007
 S 10.201 (9.349, 11.552, 27)
 C 12.315 (11.443, 13.178, 30)
Number of AgNORs per 
nucleus
ns
 S 1.000 (1.000, 1.019, 27)
 C 1.000 (1.000, 1.012, 30)
Relative AgNOR area 0.000002
 S 0.086 (0.081, 0.092, 27)
 C 0.102 (0.099, 0.113, 30)
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non-suicide cohorts. Nevertheless, the area under ROC 
curve higher than 80 % with similar sensitivity and speci-
ficity values suggests a diagnostic value of present AgNOR 
technique [53]. However, the confirmation of diagnos-
tic relevance of the method needs further study of more 
numerous cohorts.
The rDNA transcription corresponds with the growth of 
both neuronal processes and neuronal body [45]. Therefore, 
our results are concurrent with those previous neuropatho-
logical studies, where a decrease in serotonergic axonal 
endings in the PFC [54–56] and the diminished neuronal 
body size in the DRN [26] were found in suicide victims.
On the other hand, the undisturbed or augmented 
expression of the key enzyme in serotonin synthesis, tryp-
tophan hydroxylase (TPH), in DRN neurons in suicide was 
reported [16–18, 20, 22, 23, 28] (for a review see: [4]), 
which corresponds with the increased serotonin level found 
in DRN homogenates in suicide victims [57]. The produc-
tion of neurotoxic metabolites subsequent to the increased 
intracellular serotonin concentration may damage the DNA 
of DRN neurons [58], which constitutes a potent inhibitor 
of rDNA transcription [59]. Therefore, one consequence of 
the increased TPH and subsequently augmented serotonin 
level in DRN neurons may be their decreased rRNA syn-
thesis followed by deteriorated arborisation of serotonergic 
axons [60] in PFC regions.
The interpretation of our current results is not unequivo-
cal due to the complicated nature of DRN activity regula-
tion. The observed effect may be related to disturbances 
in 5HT2A receptor (5HT2AR) in limbic PFC areas, 
which provide the most afferents to the DRN [8, 61]. The 
up-regulation of 5HT2ARs in the limbic PFC was observed 
in suicide [62] (for reviews see: [29, 63, 64]). In experi-
mental models, the hyperfunction of these receptors on 
pyramidal neurons provides their increased output with 
subsequent inhibition of DRN neurons [65, 66], which may 
result in the attenuated rDNA transcription observed in our 
suicidal cohort.
On the other hand, experimental research on animal 
models suggests a sophisticated interaction between distal 
afferents and DRN neurons with an involvement of local 
circuits [65–71]. These local circuits may be dysregulated 
in suicide and thus contribute to the observed effect. The 
increased expression of presynaptic 5-HT1A auto-inhib-
itory receptors in the DRN in suicide may constitute one 
of the important local factors [72, 73]. The regionally dis-
turbed function of corticotropin-releasing hormone (CRH) 
could also contribute to the decreased rDNA transcription 
in DRN neurons in suicide [15] (for reviews on CRH func-
tion in the DRN see: [70, 74]).
The above-referenced findings point to a partially dimin-
ished protein synthesis as a consequence of the suggested 
rDNA activity decrease in the DRN in suicide. However, 
in a view of cited studies, the deteriorated rDNA activ-
ity in DRN neurons might play a fundamental role in the 
decrease of serotonergic terminals in the PFC. This abnor-
mality provides a morphological substrate for the disturbed 
serotonergic neurotransmission in the PFC with profound 
consequences for the behavioural regulation. Therefore, 
the decreased rDNA activity with subsequently diminished 
plasticity of DRN neurons may constitute one of the key 
factors in the serotonergic dysfunction in suicide.
Table 2  Summarised data 
on the confounding variables 
analysis between suicide 
victims (n = 27) and control 
subjects (n = 30)
f female, m male, q1 and q3 quartile 1 and 3, PMI post-mortem interval, BAC blood alcohol concentration, 
S suicide victims, C controls, r correlation coefficient and P P value of the Spearman’s correlation, PMI 
post-mortem interval, BAC blood alcohol concentration
Sex Age (year) PMI (h) BAC (g/l)
Intergroup comparisons
 Suicide victims: ratio/median (q, q3) 23 m/4f 43 (28, 53) 24 (24, 48) 0.0 (0.0, 2.1)
 Controls: ratio/median (q1, q3) 11 m/19f 48 (39, 61) 24 (24, 48) 0.0 (0.0, 0.0)
Statistics (suicide victims versus Controls)
 Test χ2 test U U U
 Characteristic value χ2 = 13.90 Z = 1.886 Z = − 0.280 Z = 1.846
 P value 0.0002 0.059 0.780 0.065
AgNOR parameters Group Age PMI BAC
Correlation analysis between numerical confounding variables listed above and AgNOR parameters  
revealing significant intergroup differences
AgNOR area S r/P 0.16/0.42 −0.05/0.80 0.06/0.77
C r/P 0.11/0.57 −0.20/0.28 0.18/0.33
Relative AgNOR area S r/P −0.14/0.47 0.08/0.70 0.28/0.16
C r/P 0.09/0.62 −0.04/0.85 −0.01/0.97
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Limitations
The present study has certain limitations that have to be 
considered: (1) A relatively small number of cases have 
been analysed, especially for the evaluation of potential 
diagnostic value of the method; therefore, results have 
to be confirmed in a larger sample. (2) The psychiatric 
diagnoses (also according to substance use disorders) 
and the data on possible psychotropic medication preced-
ing death were not available. The levels of psychotropic 
drugs were established only in three suicide victims 
where medication overdose constituted a cause of death. 
However, our current study did not aim at the relation 
between suicide and other mental disorders, and our pre-
vious studies did not suggest that the decreased AgNOR 
area in DRN neurons may be related to the medication 
in the last three months of life [24]. (3) The application 
of paraffin-embedded tissue is a limitation of our method 
compared to frozen brain samples, which would allow 
the application of a wider set of approaches. (4) Although 
serotonergic neurons comprise about 70 % of DRN neu-
rons [7] and nearly all the large cells in this nucleus are 
serotonergic [5, 48], we could not determine the type 
of selected neurons by AgNOR staining. Since AgNOR 
areas correspond almost 100 % to the nucleoli in DRN 
neurons, immunohistochemistry for tryptophan hydrox-
ylase with a Nissl counterstain could bring to light, 
whether the cells with reduced AgNOR areas are really 
serotonergic. Furthermore, confocal immunofluorescence 
microscopy using antibodies against nucleolin and tryp-
tophan hydroxylase could be another approach to resolve 
this issue.
Conclusion
In summary, our results suggest decreased rDNA tran-
scription in DRN neurons in suicide as a presumable 
consequence of disturbed inputs to the DRN and/or their 
local transformation. The present method could prob-
ably aid forensic differentiation diagnostics between sui-
cidal and non-suicidal death in cases where traditional 
methods do not solve this problem. However, the fur-
ther research is warranted to appropriately evaluate this 
issue.
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